Interventions for valvular disease and heart failure

Real-world multicentre experience with the Direct Flow Medical® repositionable and retrievable transcatheter aortic valve implantation system for the treatment of high-risk patients with severe aortic stenosis

EuroIntervention 2016;11:e1314-e1320 published online e-edition February 2016. DOI: 10.4244/EIJV11I11A254

Christoph Naber
Christoph K. Naber1*, MD; Stylianos A. Pyxaras1, MD; Hüseyin Ince2, MD; Azeem Latib3, MD; Peter Frambach4, MD; Peter den Heijer5, MD; Daniel Wagner4, MD; Christian Butter6, MD; Antonio Colombo3, MD; Stephan Kische2, MD
1. Contilia Heart and Vascular Centre, Elisabeth-Krankenhaus Essen, Essen, Germany; 2. Innere Medizin – Kardiologie und konservative Intensivmedizin, Vivantes Klinikum im Friedrichshain, Berlin, Germany; 3. Interventional Cardiology Unit, San Raffaele Sci

Aims: Our aim was to assess the performance of the Direct Flow Medical (DFM) repositionable and retrievable transcatheter aortic valve implantation (TAVI) system in high-risk patients wit

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

repositionabilityretrievabilitysevere aortic stenosistranscatheter aortic valve implantation
Interventions for valvular diseaseTAVITools, devices and techniques
Read next article
Edwards SAPIEN 3 implanted in a failing aortic bioprosthesis: first report

Latest news